GeneDx (WGS) News
NASDAQ: WGSHealth CareMedical/Nursing ServicesUSD
45.46-3.78 (-7.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
WGS news summary
We found 14 recent headlines mentioning GeneDx (WGS): 2 in the past week and 13 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. WGS is making an outsized move today, down 7.68% at $45.46, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "GeneDx Holdings Corp. Appoints Everett Cunningham as CEO, Succeeding Katherine Stueland", was published by Nasdaq on Nov 18, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest GeneDx headlines
- GeneDx Holdings Corp. Appoints Everett Cunningham as CEO, Succeeding Katherine StuelandOn November 15, 2026, GeneDx Holdings Corp. and Katherine Stueland agreed that Ms. Stueland will step down from her role as Chief Executive Officer and resign from the Board of Directors, effective…Nasdaq
- GeneDx names new CEOSeeking Alpha
- Why GeneDx Holdings Stock Just Dropped 16.6%Key PointsGeneDx lowered its 2026 exome and genome volume growth target to at least 28% after third-quarter testing volume fell short of expectations.Nasdaq
- GeneDx falls as Q4 outlook misses consensusSeeking Alpha
- GeneDx (WGS) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Genedx outlines Q4 revenue of at least $135M while raising 2026 adjusted net income guidance to at least $12MSeeking Alpha
- GeneDx Holdings Corp. Reports Third Quarter 2026 Financial ResultsGeneDx Holdings Corp. reported its financial results for the third quarter of 2026. Revenue grew to $123.1 million, an increase of 5% year-over-year, which included exome and genome test revenue of…Nasdaq
- GeneDx Holdings GAAP EPS of -$0.41 misses by $0.03, revenue of $123.1M beats by $0.18MSeeking Alpha
- Noteworthy Monday Option Activity: HOOD, WGS, GRPNLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Robinhood Markets Inc (Symbol: HOOD), where a total volume of 283,498 contracts…NasdaqHOOD, WGS, GRPN
- GeneDx Reports Third Quarter 2026 Financial ResultsGAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the third quarter of 2026.Business Wire
- Did GeneDx Holdings Corp. Insiders Breach their Fiduciary Duties to Shareholders?Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…PR Newswire
- GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial…Business Wire
- Noteworthy Friday Option Activity: AVGO, DELL, WGSAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Broadcom Inc (Symbol: AVGO), where a total of 235,613 contracts have traded so far,…NasdaqAVGO, DELL, WGS
- Encompass Health Expands Rehab Footprint With New Maine HospitalEHC opens a 50-bed Maine rehab hospital, expanding its footprint as strong discharge growth and planned openings support capacity expansion.NasdaqEHC, PAHC, WGS, CON